Restarting anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation: A nationwide retrospective cohort study

BACKGROUND: Resuming anticoagulation after an intracranial hemorrhage (ICH) poses a clinical conundrum. The absence of relevant guidelines has led to wide variations in the decision on resuming anticoagulation therapies after ICH. This study aimed to evaluate the risks of an anticoagulation therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Jong Youn, Bae, Gi Hwan, Jung, Jaehun, Shin, Dong Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152296/
https://www.ncbi.nlm.nih.gov/pubmed/35655532
http://dx.doi.org/10.1016/j.ijcha.2022.101037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152296/
https://www.ncbi.nlm.nih.gov/pubmed/35655532
http://dx.doi.org/10.1016/j.ijcha.2022.101037

Ejemplares similares